logo   

Insider Activity for Neumann Mark

Recent Insider Activity
Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-08-16 Intra-Cellular Therapies, Inc. Neumann Mark
(EVP, Chief Commercial Officer)
S Common Stock D 18714 $75.08 - $75.08 $1,405,047
2024-08-16 Intra-Cellular Therapies, Inc. Neumann Mark
(EVP, Chief Commercial Officer)
M Common Stock A 18714 $36.89 - $36.89 $690,359
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6